CoChat

Brain barriers in health and disease

Open access
Daneman, Richard, Engelhardt, Britta · 2017 · Neurobiology of Disease
Cited by 50

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

In all species equipped with a central nervous system (CNS), neural tissue is sequestered from the peripheral circulation by a series of barriers that tightly regulate the extracellular environment of the neural tissue (Zlokovic, 2008; Engelhardt et al., 2017; Daneman, 2012). In vertebrates, these barriers include: the blood-brain barrier formed by the endothelial cells of CNSmicrovessels,which regulatemovement ofmolecules and ions between the blood and the CNS parenchyma; the bloodcerebrospinal fluid (CSF) barriers formed by the choroid plexus epithelial cells, which generate the CSF and tightly regulate the movement of molecules between the blood and the CSF; and the meningeal barriers, which are composed of the arachnoid barrier epithelial cells and the leptomeningeal endothelial cells, which form a blood-CSF barrier around the CNS parenchyma (see Box 1). Each of these barriers sits at a vital interface between the CNS parenchyma or CSF space and the periphery, and is crucial to control the extracellular composition of the CNS to allow for proper neural function and also to protect the CNS tissue from toxins, pathogens andother potentially harmful agents. Barrier properties are achieved by a series of cellular physiological specializations. A physical barrier is realized by complex tight junctions sealing the paracellular space, and low pinocytotic activity limits transcellular trafficking across the BBB endothelium (Zlokovic, 2008; Engelhardt et al., 2017; Daneman, 2012; Rubin and Staddon, 1999). At the same time the BBB is a metabolic barrier with unique transport properties guaranteeing the efflux of non-specific small lipophilic molecules and the delivery of specific solutes. Last but not least the brain barriers strictly control leukocyte trafficking to the CNS and thus display highly specialized interactions with the leukocytes to regulate immune surveillance. Taken together these properties aim to limit the entry of non-specific molecules and cells, while delivering very specific molecules to the neural tissue (Zlokovic, 2008; Engelhardt et al., 2017; Daneman, 2012; Rubin and Staddon, 1999). Although the BBB restricts themovement of the vastmajority of solutes, this restriction is not absolute. For instance, to some degree even large molecules such as serum immunoglobulins can cross the brain barriers by a nonsaturable mechanism to reach approximately 0.1% the concentration in the CSF as that in the blood, either through non-specific vesicle trafficking, discontinuities in the TJs or other mechanisms (Yu et al., 2011). Therefore, the CNS is under constant influence from external factors. Although these barriers have largely been studied as static structures, it is now clear that they are plastic and can be dynamically altered by diet, injury, disease and other environmental factors, and can be locally regulated by neural cells, glial cells, pericytes, immune cells, extracellular matrix, blood flow, as well as systemically by factors released from other organ systems and even the gut microbiota (Weidenfeller et al., 2007; Daneman et al., 2010; Armulik et al., 2010; Janzer and Raff, 1987; Rubin et al., 1991; Braniste et al., 2014). At this point in time, we are just scraping the surface of our understanding of brain barriers as dynamic components of the CNS. An important avenue of future research moving forward will be to understand how brain barriers can sense changes to both the neural tissue and the peripheral environment, and alter their function to control the extracellular environment of the neural tissue. Many important questions still remain about how brain barriers regulate the environment of the CNS: How are different barrier properties co-ordinated to regulate the extracellular environment of the neural tissue? Is the BBB different in different brain regions to allow for the specialized functions of different brain regions?Howdynamic are the different brain barriers and how do they change with aging, exercise, stress and other stimuli? How do these barriers interact with different neural cells to regulate their development and function? Of utmost importance is the function of the brain barriers to the onset and progression of different neurological diseases. The brain is an immune privileged site demonstrated by the reduced rejection of tissue grafts transplanted into the neural tissue compared to other tissues (Medawar, 1948). One of the thoughts as to why this immune privilege occurs was that the tight barriers in place limit peripheral immune system access to the CNS. We now know that this is not absolute, as there is a complex and tightly regulated system for immune surveillance of the CNS during both health and disease. During health, the immune surveillance is largely accomplished in the ventricular CSF space and leptomeninges, and thus these blood-CSF barriers control the type and number of immune cells that gain access to the CSF compartment (Engelhardt et al., 2017). In many different neuroinflammatory diseases, brain barrier systems–including the glia limitans surrounding the entire brain parenchyma–are compromised, and serum components and immune cells are able to infiltrate from the perivascular CSF spaces across the glia limitans into the CNS parenchyma (Engelhardt et al., 2017). Thus, brain barrier dysfunction is an important component of the pathology of many different neurological diseases including stroke, multiple sclerosis, infections, traumatic brain injury, epilepsy, diabetic retinopathy and many others (Engelhardt et al., 2017; Daneman, 2012; Antonetti et al., 2012; Holman et al., 2011; Harris et al., 1991; Oby and Janigro, 2006; Alvarez et al., 2011). Brain barrier dysfunction eventually leads to loss of CNS homeostasis, which perturbs neural cell function and also allows immune molecules and cells to enter the brain which can lead to damage and ultimately degeneration. In addition to being an important component of the pathology of many diseases, brain barrier dysfunction has also been suggested to be a cause of certain neurological diseases including epilepsy and multiple sclerosis (van Vliet et al., 2015; van Vliet et al., 2007; Minagar et al., 2006). While clear leakage and immune cell infiltration are observed inmany neurological diseases, the changes to barrier function have been more controversial in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease Neurobiology of Disease 107 (2017) 1–3

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2017.05.008

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

Metadata

Authors
Daneman, R., & Engelhardt, B.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2017-11
Volume
107
Pages
1-3
ISSN
0969-9961 (ISSN-L)
OpenAlex
W2619078508
Cited by
50
References
14
FWCI
1.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.